Original Article
Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-up
1- Obesity should not be considered when selecting patients with HCC to LT as a predictive factor of HCC recurrence.
2- Recipient’s BMI at time of transplant had no direct impact on the incidence of HCC recurrence after LT, through long-term follow up, and regardless the status of the patients and their tumor characteristic at time of transplant.
2- Recipient’s BMI at time of transplant had no direct impact on the incidence of HCC recurrence after LT, through long-term follow up, and regardless the status of the patients and their tumor characteristic at time of transplant.
Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity
Diagnostic accuracy for VCTE, CAP™ and FAST score to diagnose significant and advanced fibrosis, significant and severe steatosis and NASH is only acceptable in patients with BMI≥35 kg/m² but improved in the cohort of patients below the median BMI of 44.4 kg/m2.
Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis
The meta-analysis demonstrated that SBRT provided a better effect on control of local tumor recurrence than RFA while RFA have a better survival rate than SBRT. Meanwhile, uniform standard of SBRT radiological dose and complications should be establish for further systematic review.
Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice
Transarterial infusion chemotherapy with FOLFOX regimen is effective and safe in treatment of BCLC stage C hepatocellular carcinoma. Compared with transarterial chemoembolization and sorafenib, it could improve the patient survival and bring similar rates of adverse events.
Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis
Surgery resulted in better survival in HCC patients with hepatic vein tumor thrombus compared to IMRT.
Review Article
Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO)
This consensus aims to establish a guideline worldwide to standardized the clinical practice of TACE for hepatocellular carcinoma: The consensus statements were organized into the following categories: patients’ selection, performing the procedure, TACE outcomes, repeat TACE, TACE failure/refractory, and TACE–based combination treatments.
French Editorial from the ACHBPT
Editorial
Commentary
Viewpoint
Letter to the Editor
